백신 보조제 시장 규모, 점유율, 성장 분석 : 제품별, 보조제 유형별, 투여 경로별, 질환 유형별, 용도별, 백신 유형별, 지역별
Vaccine Adjuvants Market Size, Share, and Growth Analysis, By Product, By Adjuvant Type, By Route Of Administration, By Disease Type, By Application, By Vaccine Type, By Region - Industry Forecast 2025-2032
상품코드:1663002
리서치사:SkyQuest
발행일:2025년 02월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 백신 보조제 시장 규모는 2023년 6억 7,010만 달러로 평가되었으며 2024년 7억 1,171만 달러에서 2032년 11억 5,247만 달러로 성장하여 예측 기간(2025-2032년) 동안 6.21%의 CAGR로 성장할 것으로 전망됩니다.
백신 보조제 시장은 신종 및 재출현 병원체를 포함한 전염병의 발생률 증가로 인해 상당한 성장을 보이고 있습니다. 이러한 감염병의 급증으로 효과적인 백신 접종에 대한 수요가 높아지면서 보조제는 예방 접종 효과를 높이는 데 중요한 구성 요소로 자리 잡았습니다. 특히 코로나19 이후 예방 의료에 대한 전 세계의 관심이 높아지면서 질병 예방을 위한 주요 전략으로 예방접종이 점점 더 강조되고 있습니다. 보조제는 주사 부위에서 항원의 존재를 연장하고 면역세포를 활성화하며 면역 반응을 조절하여 궁극적으로 더 강력하고 지속적인 면역을 촉진하는 중추적인 역할을 합니다. 연구 개발을 통해 다양한 질병을 대상으로 하는 혁신적인 백신이 개발됨에 따라 백신 보조제 시장은 지속적으로 확대될 것이며 성장 기회가 풍부할 것으로 전망됩니다.
목차
소개
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터의 방법
시장 규모 예측
시장의 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
억제요인과 과제
Porter's Five Forces 분석
주요 시장 인사이트
중요성공요인
경쟁도
주요 투자 기회
시장 생태계
시장의 매력 지수(2024년)
PESTEL 분석
거시경제지표
밸류체인 분석
가격 분석
규제 분석
특허 분석
백신 보조제 시장 규모 : 제품별
시장 개요
에멀젼 보조제
사포닌 기반 보조제
미립자 기반 보조제
기타 보조제
백신 보조제 시장 규모 : 보조제 유형별
시장 개요
유기 보조제
무기 보조제
백신 보조제 시장 규모 : 투여 경로별
시장 개요
근육 내
피하
기타 투여 경로
백신 보조제 시장 규모 : 질환 유형별
시장 개요
감염증
암
기타 병
백신 보조제 시장 규모 : 용도별
시장 개요
조사 용도
상용 용도
백신 보조제 시장 규모 : 백신 유형별
시장 개요
인간 백신
감염증
치료용
수의 백신
반려동물
가축
기타 동물
백신 보조제 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카
기타 중동 및 아프리카
경쟁 정보
상위 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업의 채택 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 프로파일
기업의 상세
제품 포트폴리오 분석
기업의 부문별 점유율 분석
전년대비 수익 비교(2022-2024년)
주요 기업 프로파일
GSK plc(UK)
SEPPIC(France)
Croda International Plc(UK)
SPI Pharma(USA)
Agenus Inc.(USA)
Phibro Animal Health Corporation(USA)
Aurorium(USA)
Dynavax Technologies Corporation(USA)
Novavax Inc.(USA)
Merck KGaA(Germany)
Vaxine Pty Ltd.(Australia)
Hawaii Biotech Inc.(USA)
CSL Limited(Australia)
OZ Biosciences(France)
InvivoGen(USA)
Allergy Therapeutics(UK)
EuBiologics Co., Ltd.(South Korea)
Pacific GeneTech Limited(USA)
Riboxx GmbH(Germany)
Oncovir, Inc.(USA)
결론 및 권고사항
HBR
영문 목차
영문목차
Global Vaccine Adjuvants Market size was valued at USD 670.1 million in 2023 and is poised to grow from USD 711.71 million in 2024 to USD 1152.47 million by 2032, growing at a CAGR of 6.21% during the forecast period (2025-2032).
The vaccine adjuvants market is experiencing significant growth driven by the rising incidence of infectious diseases, including both newly emerging and reemerging pathogens. This surge in infectious diseases has heightened the demand for effective vaccinations, positioning adjuvants as critical components in enhancing immunization efficacy. With a global focus on preventive healthcare, particularly post-COVID-19, there is an increasing emphasis on immunization as a primary strategy for disease prevention. Adjuvants play a pivotal role by prolonging antigen presence at the injection site, activating immune cells, and modulating the immune response, which ultimately fosters a stronger and more sustained immunity. As research and development yield innovative vaccines targeting diverse diseases, the market for vaccine adjuvants is poised for continued expansion, presenting abundant opportunities for growth.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vaccine Adjuvants market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Vaccine Adjuvants Market Segments Analysis
Global Vaccine Adjuvants Market is segmented by Product, Adjuvant Type, Route Of Administration, Disease Type, Application, Vaccine Type and region. Based on Product, the market is segmented into Emulsion Adjuvants, Pathogen Components, Saponin-Based Adjuvants, Particulate-Based Adjuvants and Other Adjuvants. Based on Adjuvant Type, the market is segmented into Organic Adjuvants and Inorganic Adjuvants. Based on Route Of Administration, the market is segmented into Intramuscular, Subcutaneous and Other Routes of Administration. Based on Disease Type, the market is segmented into Infectious Diseases, Cancer and Other Diseases. Based on Application, the market is segmented into Research Applications and Commercial Applications. Based on Vaccine Type, the market is segmented into Human Vaccines, Veterinary Vaccines and Other Animals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Vaccine Adjuvants Market
The COVID-19 pandemic has heightened global health concerns, leading to a significant rise in the demand for vaccinations, particularly those incorporating adjuvants. This trend is driven by the necessity for more effective vaccination strategies to combat a variety of infectious diseases and new emerging pathogens, which are crucial for maintaining community immunity. Consequently, vaccine manufacturers are actively seeking innovative methods to boost the potency of their vaccinations, investing in cutting-edge adjuvant technologies to enhance their effectiveness. This ongoing pursuit for improved vaccination solutions is a key driver in the Global Vaccine Adjuvants market.
Restraints in the Global Vaccine Adjuvants Market
The Global Vaccine Adjuvants market faces significant constraints due to stringent regulatory barriers that impact the licensing of these products. These strict regulations can lead to delays in the market entry of new adjuvants, ultimately increasing costs for manufacturers and creating additional challenges for business growth. Navigating the complex regulatory landscape often requires substantial resources, making it particularly difficult for smaller companies to comply with safety standards and establish a foothold in the market. This regulatory burden poses a notable hurdle, potentially stifling innovation and competition in the vaccine adjuvant sector.
Market Trends of the Global Vaccine Adjuvants Market
The Global Vaccine Adjuvants market is witnessing a significant trend towards personalized immunization plans, marking a transformative shift in vaccination strategies. As researchers increasingly focus on tailoring vaccines to individual patient profiles-considering genetic variations and specific immune responses-this approach aims to enhance vaccine efficacy and patient outcomes. By employing targeted adjuvants designed for diverse patient populations, the market is expected to drive innovation and demand for customized solutions. This evolution reflects a broader trend of precision medicine in immunization, indicating a growing commitment to improving public health through more effective and personalized vaccination strategies.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis
Patent Analysis
Global Vaccine Adjuvants Market Size by Product & CAGR (2025-2032)
Market Overview
Emulsion Adjuvants
Saponin-Based Adjuvants
Particulate-Based Adjuvants
Other Adjuvants
Global Vaccine Adjuvants Market Size by Adjuvant Type & CAGR (2025-2032)
Market Overview
Organic Adjuvants
Inorganic Adjuvants
Global Vaccine Adjuvants Market Size by Route Of Administration & CAGR (2025-2032)
Market Overview
Intramuscular
Subcutaneous
Other Routes of Administration
Global Vaccine Adjuvants Market Size by Disease Type & CAGR (2025-2032)
Market Overview
Infectious Diseases
Cancer
Other Diseases
Global Vaccine Adjuvants Market Size by Application & CAGR (2025-2032)
Market Overview
Research Applications
Commercial Applications
Global Vaccine Adjuvants Market Size by Vaccine Type & CAGR (2025-2032)
Market Overview
Human Vaccines
Infectious Diseases
Therapeutic
Veterinary Vaccines
Companion Animals
Livestock Animals
Other Animals
Global Vaccine Adjuvants Market Size & CAGR (2025-2032)
North America (Product, Adjuvant Type, Route Of Administration, Disease Type, Application, Vaccine Type)
US
Canada
Europe (Product, Adjuvant Type, Route Of Administration, Disease Type, Application, Vaccine Type)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Product, Adjuvant Type, Route Of Administration, Disease Type, Application, Vaccine Type)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Product, Adjuvant Type, Route Of Administration, Disease Type, Application, Vaccine Type)
Brazil
Rest of Latin America
Middle East & Africa (Product, Adjuvant Type, Route Of Administration, Disease Type, Application, Vaccine Type)
